Stockscreener 앱 받기
7.38
2.64%
0.19
전일 마감가:
$7.19
열려 있는:
$7.14
하루 거래량:
13,547
Relative Volume:
0.48
시가총액:
$38.97M
수익:
-
순이익/손실:
$-71.07M
주가수익비율:
-15.06
EPS:
-0.49
순현금흐름:
$-63.98M
1주 성능:
-14.39%
1개월 성능:
+36.41%
6개월 성능:
-21.15%
1년 성능:
-25.48%
1일 변동 폭
$7.0388
$7.705
1주일 범위
$7.00
$9.4568
52주 변동 폭
$4.2701
$19.00
바이케리어스 서지컬 Stock (RBOT) Company Profile
명칭
Vicarious Surgical Inc
전화
(617) 868-1700
주소
78 FOURTH AVENUE, WALTHAM
RBOT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
7.38 | 51.14M | 0 | -71.07M | -63.98M | -0.49 |
|
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
바이케리어스 서지컬 Stock (RBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 개시 | Credit Suisse | Outperform |
| 2021-12-07 | 개시 | Cowen | Outperform |
| 2021-11-05 | 개시 | Canaccord Genuity | Buy |
| 2021-10-18 | 개시 | BTIG Research | Buy |
| 2021-10-07 | 개시 | Piper Sandler | Overweight |
모두보기
바이케리어스 서지컬 주식(RBOT)의 최신 뉴스
Vicarious Surgical’s Optimistic 2025 Outlook Amid Challenges - TipRanks
Vicarious Surgical Announces New Collaboration with UMass Memorial Medical Center - marketscreener.com
Vicarious Surgical Reports Q1 2025 Financial Results - TipRanks
Vicarious Surgical, UMass partner; SS Innovations targets de novo submission - MedTech Dive
Vicarious Surgical (RBOT) Partners with UMass Memorial to Advance Robotic Surgery | RBOT Stock News - GuruFocus
Vicarious Surgical (RBOT) Nears Clinical Milestone with Innovati - GuruFocus
Vicarious Surgical Inc. (NYSE:RBOT) Q1 2025 Earnings Call Transcript - Insider Monkey
Vicarious Surgical reports net loss of USD 15.3M in Q1 2025 - Medical Buyer
Earnings call transcript: Vicarious Surgical outlines Q1 2025 progress and challenges - Investing.com UK
Vicarious Surgical’s Strategic Advancements and Milestone Achievements Justify Buy Rating - TipRanks
Vicarious Surgical Announces New Collaboration With Umass Memorial Medical Center - marketscreener.com
Vicarious Surgical Reports First Quarter 2025 Financial Results - Stock Titan
Vicarious Surgical (RBOT) to Release Quarterly Earnings on Monday - Defense World
(RBOT) Proactive Strategies - news.stocktradersdaily.com
Geode Capital Management LLC Buys 2,336 Shares of Vicarious Surgical Inc (NYSE:RBOT) - Defense World
Next-Gen Surgical Robotics Pioneer Vicarious Surgical Announces Q1 2025 Financial Results Date - Stock Titan
Vicarious Surgical to Report First Quarter 2025 Financial Results on May 12, 2025 - Bluefield Daily Telegraph
Vicarious Surgical (NYSE:RBOT) Stock Price Up 20% – Still a Buy? - Defense World
Vicarious Surgical enters consulting agreement with former CFO - MSN
(RBOT) Investment Analysis - news.stocktradersdaily.com
Vicarious Surgical receives continued listing standard notice - Medical Buyer
Vicarious Surgical receives continued listing standard notice from NYSE - MSN
Vicarious Surgical Faces NYSE Non-Compliance Notice - TipRanks
Vicarious Surgical Receives NYSE Noncompliance Notice - marketscreener.com
Vicarious Surgical Receives Continued Listing Standard Notice From The NYSE - marketscreener.com
NYSE Warning: Vicarious Surgical Must Boost Market Cap or Face Potential Delisting - Stock Titan
(RBOT) Long Term Investment Analysis - news.stocktradersdaily.com
RBOTVicarious Surgical Announces Reverse Stock Split - ADVFN
Vicarious Surgical President Randy Clark to Become Board Member - MPO-mag
Learn to Evaluate (RBOT) using the Charts - news.stocktradersdaily.com
Vicarious Surgical President Randy Clark to Transition to Board Member - citybiz
Vicarious Surgical president shifts to board role By Investing.com - Investing.com South Africa
Vicarious surgical CEO sells $1,275 in stock By Investing.com - Investing.com Australia
Vicarious Surgical Announces President Transition to Board Member Role - Ortho Spine News
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock By Investing.com - Investing.com Canada
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock - Investing.com
Vicarious surgical CEO sells $1,275 in stock - Investing.com
Vicarious Surgical president shifts to board role - Investing.com India
Vicarious Surgical announces president transition to board member role -March 24, 2025 at 04:31 pm EDT - MarketScreener
Strategic Leadership Shift: Vicarious Surgical President Elevates to Board Role After Key Achievements - Stock Titan
Vicarious Faces Another Delay for FDA Submission - MD+DI
Vicarious Surgical Inc (NYSE:RBOT) Sees Significant Growth in Short Interest - Defense World
Monogram robot wins FDA OK; Vicarious hit by supplier woes - MedTech Dive
Vicarious Surgical’s Earnings Call: Achievements and Challenges - TipRanks
Piper Sandler cuts Vicarious Surgical stock target to $8.50 By Investing.com - Investing.com Australia
Piper Sandler cuts Vicarious Surgical stock target to $8.50 - Investing.com India
BTIG maintains Neutral on Vicarious Surgical stock post-results By Investing.com - Investing.com Australia
BTIG maintains Neutral on Vicarious Surgical stock post-results - Investing.com
바이케리어스 서지컬 (RBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
0.22%
자본화:
|
볼륨(24시간):